RxDoctor Payments Data

Vincent Lobo

Family Medicine · Harrington, DENPI 1376587576

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Novo Nordisk at 44.5% of the total. Reporting peaked in 2019 at $903 and has fallen 89.2% since, to $97 in 2022.

$2,012in general payments, 2019–2025

Across 140 payments — averaging $14.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$895
  • AstraZeneca$348
  • Pfizer$207
  • Astellas Pharma US Inc$103
  • Boehringer Ingelheim$83
  • Lilly USA, LLC$75
  • plus $302 from 11 others

What the payments were for

  • Food & beverage$2,006100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,012 in reported general payments places this provider in the 75th percentile of 352 family medicine providers in Delaware.

See all family medicine providers in Delaware →

Other family medicine in Harrington

See the full list for Delaware →

Where these figures come from

Is this you, or does something look wrong? →